KDR and ductal breast carcinoma in situ: However, the VEGFR2 receptor has only shown a moderate ability to distinguish benign and malignant lesions (AUC of 0.71) in human tissues37 and only preliminary studies into the expression of VEGFR2 on high-grade DCIS have occurred37,38.